‘Transformative’: the UK lab working on a way to halt genetic type of dementia

AviadoBio’s breakthrough therapy hopes to stop progress of FTD, which is usually diagnosed in people under 65

Behind the gleaming glass facade of an office block in east London’s Docklands, Dr Martina Esposito Soccoio is pipetting ribonucleic acid into test tubes.

Here, not far from Canary Wharf’s multinational banks, a British university spinout is working on a breakthrough treatment for a form of dementia that affects millions of people worldwide.